REFERENCES
- Diehl V., Brillant C., Franklin J., et al. BEACOPP chemotherapy for advanced Hodgkin's disease: results of further analyses of the HD9- and HD12- trials of the German Hodgkin Study Group (GHSG). Blood 2004; 104(11A)307, [CSA]
- Duggan D. B.T., Petroni G. R., Johnson J. L., et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J. Clin. Oncol. 2003; 21(4)607–614, [INFOTRIEVE], [CROSSREF], [CSA]
- Loeffler M., Hasenclever D., Diehl V. Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group. Ann. Oncol. 1998; 59(Suppl. 5)S73–S78, [CROSSREF], [CSA]
- Diehl V. Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG). Ann. Hematol. 1993; 66: 139–140, [INFOTRIEVE], [CROSSREF], [CSA]
- Diehl V., Sieber M., Ruffer U., et al. BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. Ann. Oncol. 1997; 143–148, [CROSSREF], [CSA]
- Diehl V., Franklin J., Pfreundschuh M., et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N. Engl. J. Med. 2003; 348(24)2386–2395, [INFOTRIEVE], [CROSSREF], [CSA]
- Sieber M., Bredenfeld H., Josting A., et al. 14-day variant of the blemycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. J. Clin. Oncol. 2003; 21(9)1734–1739, [INFOTRIEVE], [CROSSREF], [CSA]
- Canellos G. P., Niedzwiecki D. Long-term follow-up of Hodgkin's disease trial. N. Engl. J. Med. 2002; 346(18)1417–1418, [INFOTRIEVE], [CROSSREF], [CSA]
- Hasenclever D., Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N. Engl. J. Med. 1998; 339(21)1506–1514, [INFOTRIEVE], [CROSSREF], [CSA]
- Raemaekers J., Kluin-Nelemans H., Teodorovic I., , The achievements of the EORTC Lymphoma Group, et al. European Organisation for Research and Treatment of Cancer. Eur. J. Cancer 2002; 38(Suppl. 4)S107–S113, [INFOTRIEVE], [CROSSREF], [CSA]